

Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "BlackRock Inc.."
12 result(s) displayed (1 - 12 of 18)
The acquisition is the New York fund manager's third in recent months in German-speaking Europe. Continue reading
Posted on January 10, 2013 8:43 AM
Jim Bob Moffett's latest move may just be flashy enough to elude activists who try to take him down. Continue reading
Posted on December 17, 2012 9:25 AM
The target's board sustains heavy criticism for its handling of the transaction and fails in its bid to award transferring managers close to $230 million in retention bonuses. Continue reading
Posted on November 20, 2012 2:54 PM
After the company releases positive Phase 2b data on eteplirsen, a compound that treats Duchenne muscular dystrophy, talk turns to the possibility of a takeover Continue reading
Posted on July 25, 2012 9:22 AM
The London institution prices the secondary offering at a 2.1% discount to BlackRock's closing price Tuesday Continue reading
Posted on May 23, 2012 9:33 AM
The New York fund manager expects to buy back $1 billion of the holding Continue reading
Posted on May 21, 2012 12:01 PM
Teacher Retirement System of Texas and New Jersey's State Investment Council have fine-tuned PE allocations by devising SMAs. Continue reading
Posted on March 30, 2012 12:00 PM
The fusion would create a commodities trading and mining giant worth more than $100 billion. Continue reading
Posted on February 2, 2012 6:05 PM
The megabank successfully divested more than $30 billion in assets last year at a time when big deals were scarce. Continue reading
Posted on January 20, 2012 12:00 PM
By hanging a for-sale sign, the London-listed gas prospector sent its value up about 10% to £605 million ($945 million). Continue reading
Posted on January 5, 2012 11:18 AM
The private equity firm's $19 per share offer for the dental services provider is an 83% premium to the target's Friday closing price. Continue reading
Posted on November 9, 2011 12:10 PM
Bard, which manufactures medical technologies in the vascular, urology, oncology, and surgical specialty products fields, will pay $250 million for Medivance. Continue reading
Posted on October 26, 2011 3:40 PM
Movable Type search results powered by Fast Search